In the BioHarmony Drug Report Database
Provigil (modafinil) is a small molecule pharmaceutical. Modafinil was first approved as Provigil on 1998-12-24. It is used to treat attention deficit disorder with hyperactivity, fatigue, narcolepsy, and obstructive sleep apnea in the USA. It is known to target sodium-dependent dopamine transporter. Provigil’s patent is valid until 2023-11-29 (FDA).
Image (chem structure or protein)